Diskussion zur BICO Group Aktie WKN: A2PX00 ISIN: SE0013647385 Forum: Aktien User: Hedgehog3
Home » BICO news feed BICO News Feed Discover the latest news from our business areas. September 28, 2023 11:56 am CELLINK Expands Bioprinting Reach in Portugal and Spain through Strategic Partnership with Paralab Share on facebook Share on twitter Share on linkedin CELLINK, a global leader in 3D bioprinting technologies, is excited to announce a strategic distribution agreement with Paralab, marking a significant expansion of its presence in Portugal and Spain. This collaboration brings CELLINK’s state-of-the-art bioprinting solutions to a broader audience in Southern Europe, reinforcing the company’s commitment to advancing regenerative medicine while respecting regional nuances. Paralab has more than 30 years of experience in distributing scientific equipment for industrial and laboratory applications. This partnership, driven by a mutual commitment to empowering researchers and advancing scientific discovery, holds the potential to be a transformative development for the local bioprinting community. By leveraging Paralab’s strong regional presence and reputation, along with CELLINK’s cutting-edge bioprinting solutions, Paralab along with its Bio division, is strategically positioned to offer prompt assistance and service to CELLINK’s bioprinting solution users. The collaboration will prioritize knowledge sharing, training, and technical support, ensuring that researchers in Portugal and Spain can fully harness the capabilities of CELLINK’s cutting-edge bioprinting platforms. This partnership exemplifies CELLINK’s continued expansion efforts and its dedication to enhancing the accessibility of bioprinting technologies on a global scale. With Paralab’s well-established distribution network, researchers, scientists, and institutions in Portugal and Spain will now find it easier than ever to access CELLINK’s advanced bioprinters and bioinks. “We are thrilled to embark on this journey with Paralab and expand our presence in Southern Europe,” stated Andrew Ridley, Head of Sales Europe, CELLINK. “Their track record of excellence, strong local presence, and commitment to customer success align with CELLINK’s core values. We are confident that this collaboration will empower researchers in Portugal and Spain to drive forward groundbreaking research in regenerative medicine, tissue engineering, and beyond.” “We are glad we could celebrate this strategic collaboration between CELLINK and ParalabBIO which represents a commitment to advancing scientific knowledge and innovation in the field of 3D bioprinting. Together, we aim to reshape the future of 3D bioprinting in Portugal and Spain by bringing to our valued customers cutting edge technology and streamline operations with even greater value.” José Catita, Senior Manager, Paralab & ParalabBIO
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | BED BATH & BEYOND Hauptdiskussion | ±0,00 % | |
| 2 | SUNHYDROGEN | -0,40 % | |
| 3 | SIRONA BIOCHEM Hauptdiskussion | +2,87 % | |
| 4 | GAMESTOP Hauptdiskussion | +1,18 % | |
| 5 | Hauptforum Everfuel | -3,93 % | |
| 6 | DPCM Capital Hauptdiskussion | +8,47 % | |
| 7 | TELADOC HEALTH INC.DL-001 Hauptdiskussion | +4,56 % | |
| 8 | Solid Power Inc. | +2,79 % | |
| 9 | Nio für normale Kommunikation | +0,89 % | |
| 10 | Trading- und Aktien-Chat | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | BED BATH & BEYOND Hauptdiskussion | ±0,00 % | |
| 2 | SUNHYDROGEN | -0,40 % | |
| 3 | SIRONA BIOCHEM Hauptdiskussion | +2,87 % | |
| 4 | GAMESTOP Hauptdiskussion | +1,18 % | |
| 5 | Hauptforum Everfuel | -3,93 % | |
| 6 | DPCM Capital Hauptdiskussion | +8,47 % | |
| 7 | TELADOC HEALTH INC.DL-001 Hauptdiskussion | +4,56 % | |
| 8 | Solid Power Inc. | +2,79 % | |
| 9 | Nio für normale Kommunikation | +0,89 % | |
| 10 | FuelCell Energy Hauptdiskussion | -2,60 % | Alle Diskussionen |